text:
Olaudah Equiano

Olaudah Equiano (c. 1745 – 31 March 1797), known for most of his life as Gustavus Vassa, was a writer and abolitionist. According to his memoir, he was from the village of Essaka in modern southern Nigeria. Enslaved as a child in West Africa, he was shipped to the Caribbean and sold to a Royal Navy officer. He was sold twice more before purchasing his freedom in 1766.

As a freedman in London, Equiano supported the British abolitionist movement, in the 1780s becoming one of its leading figures. Equiano was part of the abolitionist group the Sons of Africa, whose members were Africans living in Britain. His 1789 autobiography, The Interesting Narrative of the Life of Olaudah Equiano, sold so well that nine editions were published during his life and helped secure passage of the British Slave Trade Act 1807, which abolished the slave trade. The Interesting Narrative gained renewed popularity among scholars in the late 20th century and remains a useful primary source.

Early life and enslavement
According to his memoir, Equiano was born around 1745 in the Igbo village of Essaka in what is now southern Nigeria. He claimed his home was part of the Kingdom of Benin.

Equiano recounted an incident of an attempted kidnapping of children in his Igbo village, which was foiled by adults. When he was around the age of eleven, he and his sister were left alone to look after their family premises, as was common when adults went out of the house to work. They were kidnapped and taken far from their home, separated and sold to slave traders. He tried to escape but was thwarted. After his owners changed several times, Equiano happened to meet with his sister but they were separated again. Six or seven months after he had been kidnapped, he arrived at the coast where he was taken on board a European slave ship. He was transported with 244 other enslaved Africans across the Atlantic Ocean to Barbados in the British West Indies. He and a few other slaves were sent on for sale in the Colony of Virginia.

Literary scholar Vincent Carretta argued in his 2005 biography of Equiano that the activist could have been born in colonial South Carolina rather than Africa, based on a 1759 parish baptismal record that lists Equiano's place of birth as Carolina and a 1773 ship's muster that indicates South Carolina. Carretta's conclusion is disputed by other scholars who believe the weight of evidence supports Equiano's account of coming from Africa.

In Virginia, Equiano was bought by Michael Henry Pascal, a lieutenant in the Royal Navy. Pascal renamed the boy "Gustavus Vassa", after the 16th-century King of Sweden Gustav Vasa who began the Protestant Reformation in Sweden. Equiano had already been renamed twice: he was called Michael while on board the slave ship that brought him to the Americas, and Jacob by his first owner. This time, Equiano refused and told his new owner that he would prefer to be called Jacob. His refusal, he says, "gained me many a cuff" and eventually he submitted to the new name. He used this name for the rest of his life, including on all official records; he only used Equiano in his autobiography.

Pascal took Equiano with him when he returned to England and had him accompany him as a valet during the Seven Years' War with France (1756–1763). Equiano gives witness reports of the Siege of Louisbourg (1758), the Battle of Lagos (1759) and the Capture of Belle Île (1761). Also trained in seamanship, Equiano was expected to assist the ship's crew in times of battle; his duty was to haul gunpowder to the gun decks. Pascal favoured Equiano and sent him to his sister-in-law in Great Britain so that he could attend school and learn to read and write.

Equiano converted to Christianity and was baptised at St Margaret's, Westminster, on 9 February 1759, when he was described in the parish register as "a Black, born in Carolina, 12 years old". His godparents were Mary Guerin and her brother, Maynard, who were cousins of his master Pascal. They had taken an interest in him and helped him to learn English. Later, when Equiano's origins were questioned after his book was published, the Guerins testified to his lack of English when he first came to London.

In December 1762, Pascal sold Equiano to Captain James Doran of the Charming Sally at Gravesend, from where he was transported back to the Caribbean, to Montserrat, in the Leeward Islands. There, he was sold to Robert King, an American Quaker merchant from Philadelphia who traded in the Caribbean.

Release
Robert King set Equiano to work on his shipping routes and in his stores. In 1765, when Equiano was about 20 years old, King promised that for his purchase price of 40 pounds he could buy his freedom. King taught him to read and write more fluently, guided him along the path of religion, and allowed Equiano to engage in profitable trading for his own account, as well as on his owner's behalf. Equiano sold fruits, glass tumblers and other items between Georgia and the Caribbean islands. King allowed Equiano to buy his freedom, which he achieved in 1766. The merchant urged Equiano to stay on as a business partner. However, Equiano found it dangerous and limiting to remain in the British colonies as a freedman. While loading a ship in Georgia, he was almost kidnapped back into enslavement.

Freedom
By about 1768, Equiano had gone to Britain. He continued to work at sea, travelling sometimes as a deckhand based in England. In 1773 on the Royal Navy ship HMS Racehorse, he travelled to the Arctic in an expedition towards the North Pole. On that voyage he worked with Dr Charles Irving, who had developed a process to distill seawater and later made a fortune from it. Two years later, Irving recruited Equiano for a project on the Mosquito Coast in Central America, where he was to use his African background to help select slaves and manage them as labourers on sugar-cane plantations. Irving and Equiano had a working relationship and friendship for more than a decade, but the plantation venture failed. Equiano met with George, the "Musquito king's son".

Equiano left the Mosquito Coast in 1776 and arrived at Plymouth, England, on 7 January 1777.

Pioneer of the abolitionist cause
Equiano settled in London, where in the 1780s he became involved in the abolitionist movement. The movement to end the slave trade had been particularly strong among Quakers, but the Society for Effecting the Abolition of the Slave Trade was founded in 1787 as a non-denominational group, with Anglican members, in an attempt to influence parliament directly. Under the Test Act, only those prepared to receive the sacrament of the Lord's Supper according to the rites of the Church of England were permitted to serve as MPs. Equiano had been influenced by George Whitefield's evangelism.

As early as 1783, Equiano informed abolitionists such as Granville Sharp about the slave trade; that year he was the first to tell Sharp about the Zong massacre, which was being tried in London as litigation for insurance claims. It became a cause célèbre for the abolitionist movement and contributed to its growth.

On 21 October 1785 he was one of eight delegates from Africans in America to present an 'Address of Thanks' to the Quakers at a meeting in Gracechurch Street, London. The address referred to A Caution to Great Britain and her Colonies by Anthony Benezet, founder of the Society for the Relief of Free Negroes Unlawfully Held in Bondage.

Equiano was befriended and supported by abolitionists, many of whom encouraged him to write and publish his life story. He was supported financially in this effort by philanthropic abolitionists and religious benefactors. His lectures and preparation for the book were promoted by, among others, Selina Hastings, Countess of Huntingdon.

Memoir
Entitled The Interesting Narrative of the Life of Olaudah Equiano, or Gustavus Vassa, the African (1789), the book went through nine editions in his lifetime. It is one of the earliest-known examples of published writing by an African writer to be widely read in England. By 1792, it was a best seller and had been published in Russia, Germany, Holland and the United States. It was the first influential slave narrative of what became a large literary genre. But Equiano's experience in slavery was quite different from that of most slaves; he did not participate in field work, he served his owners personally and went to sea, was taught to read and write, and worked in trading.

Equiano's personal account of slavery, his journey of advancement, and his experiences as a black immigrant caused a sensation on publication. The book fuelled a growing anti-slavery movement in Great Britain, Europe and the New World. His account surprised many with the quality of its imagery, description and literary style.

In his account, Equiano gives details about his hometown and the laws and customs of the Eboe people. After being captured as a boy, he described communities he passed through as a captive on his way to the coast. His biography details his voyage on a slave ship and the brutality of slavery in the colonies of the West Indies, Virginia and Georgia.

Equiano commented on the reduced rights that freed people of colour had in these same places, and they also faced risks of kidnapping and enslavement. Equiano embraced Christianity at the age of 14 and its importance to him is a recurring theme in his autobiography. He was baptised into the Church of England in 1759; he described himself in his autobiography as a "protestant of the church of England" but also flirted with Methodism.

Several events in Equiano's life led him to question his faith. He was distressed in 1774 by the kidnapping of his friend, a black cook named John Annis, who was taken forcibly off the British ship Anglicania on which they were both serving. His friend's kidnapper, William Kirkpatrick, did not abide by the decision in the Somersett Case (1772), that slaves could not be taken from England without their permission, as common law did not support the institution in England & Wales. Kirkpatrick had Annis transported to Saint Kitts, where he was punished severely and worked as a plantation labourer until he died. With the aid of Granville Sharp, Equiano tried to get Annis released before he was shipped from England but was unsuccessful. He heard that Annis was not free from suffering until he died in slavery. Despite his questioning, he affirms his faith in Christianity, as seen in the penultimate sentence of his work that quotes the prophet Micah : "After all, what makes any event important, unless by its observation we become better and wiser, and learn 'to do justly, to love mercy, and to walk humbly before God?'"

In his account, Equiano also told of his settling in London. He married an English woman and lived with her in Soham, Cambridgeshire, where they had two daughters. He became a leading abolitionist in the 1780s, lecturing in numerous cities against the slave trade. Equiano records his and Granville Sharp's central roles in the anti-slave trade movement, and their effort to publicise the Zong massacre, which became known in 1783.

Reviewers have found that his book demonstrated the full and complex humanity of Africans as much as the inhumanity of slavery. The book was considered an exemplary work of English literature by a new African author. Equiano did so well in sales that he achieved independence from his benefactors. He travelled throughout England, Scotland and Ireland promoting the book, spending eight months in Ireland alone between 1792-3. He worked to improve economic, social and educational conditions in Africa. Specifically, he became involved in working in Sierra Leone, a colony founded in 1792 for freed slaves by Britain in West Africa.

Later years, radical connections
During the American Revolutionary War, Britain had recruited black people to fight with it by offering freedom to those who left rebel masters. In practice, it also freed women and children, and attracted thousands of slaves to its lines in New York City, which it occupied, and in the South, where its troops occupied Charleston, South Carolina. When British troops were evacuated at the end of the war, their officers also evacuated these former American slaves. They were resettled in the Caribbean, in Nova Scotia, in Sierra Leone in Africa, and in London. Britain refused to return the slaves, which the United States sought in peace negotiations.

In 1783, following the United States' gaining independence, Equiano became involved in helping the Black Poor of London, who were mostly those former African-American slaves freed during and after the American Revolution by the British. There were also some freed slaves from the Caribbean, and some who had been brought by their owners to England and freed later after the decision that Britain had no basis in common law for slavery. The black community numbered about 20,000. After the Revolution some 3,000 former slaves had been transported from New York to Nova Scotia, where they became known as Black Loyalists, among other Loyalists also resettled there. Many of the freedmen found it difficult to make new lives in London or Canada.

Equiano was appointed "Commissary of Provisions and Stores for the Black Poor going to Sierra Leone" in November 1786. This was an expedition to resettle London's Black Poor in Freetown, a new British colony founded on the west coast of Africa, in present-day Sierra Leone. The blacks from London were joined by more than 1,200 Black Loyalists who chose to leave Nova Scotia. They were aided by John Clarkson, younger brother of abolitionist Thomas Clarkson. Jamaican maroons, as well as slaves liberated from illegal slave-trading ships after Britain abolished the slave trade, also settled at Freetown in the early decades. Equiano was dismissed from the new settlement after protesting against financial mismanagement and he returned to London.

Equiano was a prominent figure in London and often served as a spokesman for the black community. He was one of the leading members of the Sons of Africa, a small abolitionist group composed of free Africans in London. They were closely allied with the Society for the Abolition of the Slave Trade. Equiano's comments on issues were published in newspapers such as the Public Advertiser and the Morning Chronicle. He replied to James Tobin in 1788, in the Public Advertiser, attacking two of his pamphlets and a related book from 1786 by Gordon Turnbull. Equiano had more of a public voice than most Africans or Black Loyalists and he seized various opportunities to use it.

Equiano was an active member of the radical working-class London Corresponding Society, which campaigned for democratic reform. In 1791–92, touring the British Isles with his autobiography and drawing on abolitionist networks he brokered connections for the LCS, including what may have been the Society's first contacts with the United Irishmen. In Belfast, where his appearance in May 1791 was celebrated by abolitionists who five years previously had defeated plans to commission vessels in the port for the Middle Passage, Equiano was hosted by the leading United Irishman, publisher of their Painite newspaper the Northern Star, Samuel Neilson. Following the onset of war with revolutionary France, leading members of the LCS, including Thomas Hardy with whom Equiano lodged in 1792, were charged with treason, and in 1799, following evidence of communication between leading members and the insurrectionary United Irishmen, the society was suppressed.

Marriage and family
On 7 April 1792, Equiano married Susannah Cullen, a local woman, in St Andrew's Church, Soham, Cambridgeshire. The original marriage register containing the entry for Vassa and Cullen is held today by the Cambridgeshire Archives and Local Studies. He included his marriage in every edition of his autobiography from 1792 onwards. The couple settled in the area and had two daughters, Anna Maria (1793–1797) and Joanna (1795–1857) who were baptised at Soham church.

Susannah died in February 1796, aged 34, and Equiano died a year after that on 31 March 1797. Soon after, Anna died at the age of four, leaving Joanna to inherit Equiano's estate when she was 21; it was then valued at £950. Anna Maria is commemorated by a plaque at St Andrew's Church, Chesterton, Cambridge. Joanna Vassa married the Reverend Henry Bromley, a Congregationalist minister, in 1821. They are both buried at the non-denominational Abney Park Cemetery in Stoke Newington, London; the Bromleys' monument is now a Grade II listed building.

Last days and will
He drew up his will on 28 May 1796. At the time he was living at the Plaisterers' Hall, then on Addle Street, in Aldermanbury in the City of London. He moved to John Street (now Whitfield Street), close to Whitefield's Tabernacle, Tottenham Court Road. At his death on 31 March 1797, he was living in Paddington Street, Westminster. Equiano's death was reported in American as well as British newspapers.

Equiano was buried at Whitefield's Tabernacle on 6 April. The entry in the register reads "Gustus Vasa, 52 years, St Mary Le bone". His burial place has been lost. The small burial ground lay either side of the chapel and is now Whitfield Gardens. The site of the chapel is now the American International Church.

Equiano's will, in the event of his daughters' deaths before reaching the age of 21, bequeathed half his wealth to the Sierra Leone Company for a school in Sierra Leone, and half to the London Missionary Society.

Controversy related to memoir
Following publication in 1967 of a newly edited version of his memoir by Paul Edwards, interest in Equiano revived. Scholars from Nigeria have also begun studying him. For example, S.S. Ogede identifies Equiano as a pioneer in asserting "the dignity of African life in the white society of his time".

In researching his life, some scholars since the late 20th century have disputed Equiano's account of his origins. In 1999 while editing a new version of Equiano's memoir, Vincent Carretta, a professor of English at the University of Maryland, found two records that led him to question the former slave's account of being born in Africa. He first published his findings in the journal Slavery and Abolition. At a 2003 conference in England, Carretta defended himself against Nigerian academics, like Obiwu, who accused him of "pseudo-detective work" and indulging "in vast publicity gamesmanship". In his 2005 biography, Carretta suggested that Equiano may have been born in South Carolina rather than Africa, as he was twice recorded from there. Carretta wrote:

"Equiano was certainly African by descent. The circumstantial evidence that Equiano was also African-American by birth and African-British by choice is compelling but not absolutely conclusive. Although the circumstantial evidence is not equivalent to proof, anyone dealing with Equiano's life and art must consider it."

According to Carretta, Equiano/Vassa's baptismal record and a naval muster roll document him as from South Carolina. Carretta interpreted these anomalies as possible evidence that Equiano had made up the account of his African origins, and adopted material from others. But Paul Lovejoy, Alexander X. Byrd and Douglas Chambers note how many general and specific details Carretta can document from sources that related to the slave trade in the 1750s as described by Equiano, including the voyages from Africa to Virginia, sale to Pascal in 1754, and others. They conclude he was more likely telling what he understood as fact, rather than creating a fictional account; his work is shaped as an autobiography.

Lovejoy wrote that:

"circumstantial evidence indicates that he was born where he said he was, and that, in fact, The Interesting Narrative is reasonably accurate in its details, although, of course, subject to the same criticisms of selectivity and self-interested distortion that characterize the genre of autobiography."

Lovejoy uses the name of Vassa in his article, since that was what the man used throughout his life, in "his baptism, his naval records, marriage certificate and will". He emphasises that Vassa only used his African name in his autobiography.

Other historians also argue that the fact that many parts of Equiano's account can be proven lends weight to accepting his account of African birth. As historian Adam Hochschild has written:

"In the long and fascinating history of autobiographies that distort or exaggerate the truth. ... Seldom is one crucial portion of a memoir totally fabricated and the remainder scrupulously accurate; among autobiographers ... both dissemblers and truth-tellers tend to be consistent."

He also noted that "since the 'rediscovery' of Vassa's account in the 1960s, scholars have valued it as the most extensive account of an eighteenth-century slave's life and the difficult passage from slavery to freedom".

Legacy

 * The Equiano Society was formed in London in November 1996. Its main objective is to publicise and celebrate the life and work of Olaudah Equiano.
 * In 1789 Equiano moved to 10 Union Street (now 73 Riding House Street). A City of Westminster commemorative green plaque was unveiled there on 11 October 2000 as part of Black History Month. Student musicians from Trinity College of Music played a fanfare composed by Professor Ian Hall for the unveiling.
 * Equiano is honoured in the Church of England and remembered in its Calendar of saints with a Lesser Festival on 30 July, along with Thomas Clarkson and William Wilberforce who worked for abolition of the slave trade and slavery.
 * In 2007, the year of the celebration in Britain of the bicentenary of the abolition of the slave trade, Equiano's life and achievements were included in the National Curriculum, together with William Wilberforce. In December 2012 The Daily Mail claimed that both would be dropped from the curriculum, a claim which itself became subject to controversy. In January 2013 Operation Black Vote launched a petition to request Education Secretary Michael Gove to keep both Equiano and Mary Seacole in the National Curriculum. American Rev. Jesse Jackson and others wrote a letter to The Times protesting against the mooted removal of both figures from the National Curriculum.
 * A statue of Equiano, made by pupils of Edmund Waller School, was erected in Telegraph Hill Lower Park, New Cross, London, in 2008.
 * The head of Equiano is included in Martin Bond's 1997 sculpture Wall of the Ancestors in Deptford, London
 * Author Ann Cameron adapted Equiano's autobiography for children, leaving most of the text in Equiano's own words; the book was published in 1995 in the U.S. by Random House as The Kidnapped Prince: The Life of Olaudah Equiano, with an introduction by historian Henry Louis Gates Jr.
 * On 16 October 2017, Google Doodle honoured Equiano by celebrating the 272nd year since his birth.
 * A crater on Mercury was named "Equiano" in 1976.
 * The exoplanet HD 43197 b was officially named Equiano in 2019 as part of NameExoWorlds.
 * In 2019, Google Cloud named a subsea cable running from Portugal through the West Coast of Africa and terminating in South Africa after Equiano.
 * In 2022, the city of Cambridge honoured Equiano by renaming Riverside Bridge to Equiano Bridge.

Representation in other media

 * The Gambian actor Louis Mahoney played Equiano in the BBC television mini-series The Fight Against Slavery (1975).
 * A 28-minute documentary, Son of Africa: The Slave Narrative of Olaudah Equiano (1996), produced by the BBC and directed by Alrick Riley, uses dramatic reconstruction, archival material and interviews to provide the social and economic context for his life and the slave trade.

Numerous works about Equiano have been produced for and since the 2007 bicentenary of Britain's abolition of the slave trade:
 * Equiano was portrayed by the Senegalese musician Youssou N'Dour in the film Amazing Grace (2006).
 * African Snow (2007), a play by Murray Watts, takes place in the mind of John Newton, a captain in the slave trade who later became an Anglican cleric and hymnwriter. It was first produced at the York Theatre Royal as a co-production with Riding Lights Theatre Company, transferring to the Trafalgar Studios in London's West End and a national tour. Newton was played by Roger Alborough and Equiano by Israel Oyelumade.
 * Kent historian Dr Robert Hume wrote a children's book entitled Equiano: The Slave with the Loud Voice (2007), illustrated by Cheryl Ives.
 * David and Jessica Oyelowo appeared as Olaudah and his wife in Grace Unshackled – The Olaudah Equiano Story (2007), a BBC 7 radio adaptation of Equiano's autobiography.
 * The British jazz artist Soweto Kinch's first album, Conversations with the Unseen (2003), contains a track entitled "Equiano's Tears".
 * Equiano was portrayed by Jeffery Kissoon in Margaret Busby's 2007 play An African Cargo, staged at London's Greenwich Theatre.
 * Equiano is portrayed by Danny Sapani in the BBC series Garrow's Law (2010).
 * The Nigerian writer Chika Unigwe has written a fictional memoir of Equiano: The Black Messiah, originally published in Dutch: De zwarte messias (2013).
 * In Jason Young's 2007 short animated film, The Interesting Narrative of Olaudah Equiano, Chris Rochester portrayed Equiano.
 * A TikTok series under the account @equiano.stories recounts "the true story of Olaudah Equiano", a collection of episodes reimagining the childhood of Equiano. The story is captured as a self-recorded, first-person account, within the format of Instagram Stories/TikTok posts, using video, still images, and text.
 * In 2022 a documentary entitled The Amazing Life of Olaudah Equiano was broadcast by BBC Radio 4.

title: Olaudah Equiano


text:
Women's health

Women's health differs from that of men's health in many unique ways. Women's health is an example of population health, where health is defined by the World Health Organization (WHO) as "a state of complete physical, mental and social well-being and not merely the absence of disease or infirmity". Often treated as simply women's reproductive health, many groups argue for a broader definition pertaining to the overall health of women, better expressed as "The health of women". These differences are further exacerbated in developing countries where women, whose health includes both their risks and experiences, are further disadvantaged.

While the rates of the leading causes of death, cardiovascular disease, cancer and lung disease, are similar in women and men, women have different experiences. Lung cancer has overtaken all other types of cancer as the leading cause of cancer related death in women, followed by breast cancer, colorectal, ovarian, uterine and cervical cancers. While smoking is the major cause of lung cancer, amongst nonsmoking women the risk of developing cancer is three times greater than among nonsmoking men. Despite this, breast cancer remains the most common cancer in women in developed countries, and is one of the major chronic diseases of women, while cervical cancer remains one of the most common cancers in developing countries, associated with human papilloma virus (HPV), a sexually transmitted infection. HPV vaccine together with screening offers the promise of controlling these diseases. Other important health issues for women include cardiovascular disease, depression, dementia, osteoporosis and anemia.

In 176 out of 178 countries for which records are available, there is a gender gap in favor of women in life expectancy. In Western Europe, this has been the case at least as far back as 1750. Gender remains an important social determinant of health, since women's health is influenced not just by their biology but also by conditions such as poverty, employment, and family responsibilities. Women have long been disadvantaged in many respects such as social and economic power which restricts their access to the necessities of life including health care, and the greater the level of disadvantage, such as in developing countries, the greater adverse impact on health.

Women's reproductive and sexual health has a distinct difference compared to men's health. Even in developed countries, pregnancy and childbirth are associated with substantial risks to women with maternal mortality accounting for more than a quarter of a million deaths per year, with large gaps between the developing and developed countries. Comorbidity from other non-reproductive diseases such as cardiovascular disease contribute to both the mortality and morbidity of pregnancy, including preeclampsia. Sexually transmitted infections have serious consequences for women and infants, with mother-to-child transmission leading to outcomes such as stillbirths and neonatal deaths, and pelvic inflammatory disease leading to infertility. In addition, infertility from many other causes, birth control, unplanned pregnancy, rape and the struggle for access to abortion create other burdens for women.

Definitions and scope
Women's experience of health and disease differ from those of men, due to unique biological, social and behavioral conditions. Biological differences vary from phenotypes to the cellular biology, and manifest unique risks for the development of ill health. WHO defines health as "a state of complete physical, mental and social well-being and not merely the absence of disease or infirmity". Women's health is an example of population health, the health of a specific defined population.

Women's health has been described as "a patchwork quilt with gaps". Although many of the issues around women's health relate to their reproductive health, including maternal and child health, genital health and breast health, and endocrine (hormonal) health, including menstruation, birth control and menopause, a broader understanding of women's health to include all aspects of the health of women has been urged, replacing "Women's Health" with "The Health of Women". WHO considers that an undue emphasis on reproductive health has been a major barrier to ensuring access to good quality health care for all women. Conditions that affect both men and women, such as cardiovascular disease, osteoporosis, also manifest differently in women. Women's health issues also include medical situations in which women face problems not directly related to their biology, such as gender-differentiated access to medical treatment and other socioeconomic factors. Women's health is of particular concern due to widespread discrimination against women in the world, leaving them disadvantaged.

A number of health and medical research advocates, such as the Society for Women's Health Research in the United States, support this broader definition, rather than merely issues specific to human female anatomy to include areas where biological sex differences between women and men exist. Women also need health care more and access the health care system more than do men. While part of this is due to their reproductive and sexual health needs, they also have more chronic non-reproductive health issues such as cardiovascular disease, cancer, mental illness, diabetes and osteoporosis. Another important perspective is realising that events across the entire life cycle (or life-course), from in utero to aging effect the growth, development and health of women. The life course perspective is one of the key strategies of the World Health Organization.

Global perspective
Gender differences in susceptibility and symptoms of disease and response to treatment in many areas of health are particularly true when viewed from a global perspective. Much of the available information comes from developed countries, yet there are marked differences between developed and developing countries in terms of women's roles and health. The global viewpoint is defined as the "area for study, research and practice that places a priority on improving health and achieving health equity for all people worldwide". In 2015 the World Health Organization identified the top ten issues in women's health as being cancer, reproductive health, maternal health, human immunodeficiency virus (HIV), sexually transmitted infections, violence, mental health, non communicable diseases, youth and aging.

Life expectancy
Women's life expectancy is greater than that of men, and they have lower death rates throughout life, regardless of race and geographic region. Historically though, women had higher rates of mortality, primarily from maternal deaths (death in childbirth). In industrialised countries, particularly the most advanced, the gender gap narrowed and was reversed following the industrial revolution. Despite these differences, in many areas of health, women experience earlier and more severe disease, and experience poorer outcomes.

Despite these differences, the leading causes of death in the United States are remarkably similar for men and women, headed by heart disease, which accounts for a quarter of all deaths, followed by cancer, lung disease and stroke. While women have a lower incidence of death from unintentional injury and suicide, they have a higher incidence of dementia.

The major differences in life expectancy for women between developed and developing countries lie in the childbearing years. If a woman survives this period, the differences between the two regions become less marked, since in later life non-communicable diseases (NCDs) become the major causes of death in women throughout the world, with cardiovascular deaths accounting for 45% of deaths in older women, followed by cancer (15%) and lung disease (10%). These create additional burdens on the resources of developing countries. Changing lifestyles, including diet, physical activity and cultural factors that favour larger body size in women, are contributing to an increasing problem with obesity and diabetes amongst women in these countries and increasing the risks of cardiovascular disease and other NCDs.

Women who are socially marginalised are more likely to die at younger ages than women who are not. Women who have substance abuse disorders, who are homeless, who are sex workers, and/or who are imprisoned have significantly shorter lives than other women. At any given age, women in these overlapping, stigmatised groups are approximately 10 to 13 times more likely to die than typical women of the same age.

Social and cultural factors
Women's health is positioned within a wider body of knowledge cited by, amongst others, the World Health Organization, which places importance on gender as a social determinant of health. While women's health is affected by their biology, it is also affected by their social conditions, such as poverty, employment, and family responsibilities, and these aspects should not be overshadowed.

Women have traditionally been disadvantaged in terms of economic and social status and power, which in turn reduces their access to the necessities of life including health care. Despite recent improvements in Western nations, women remain disadvantaged with respect to men. The gender gap in health is even more acute in developing countries where women are relatively more disadvantaged. In addition to gender inequity, there remain specific disease processes uniquely associated with being a woman which create specific challenges in both prevention and health care.

Deeply ingrained cultural, religious, and patriarchal systems within the MENA region perpetuate gender-based power dynamics within communities and lead to discrepancies in healthcare access. In a speech, UNFPA executive director Thoraya Ahmed Obaid outlined these difficulties and emphasized the need to change cultural and societal norms in order to improve the health of women in the area.

Even after succeeding in accessing health care, women have been discriminated against, a process that Iris Young has called "internal exclusion", as opposed to "external exclusion", the barriers to access. This invisibility effectively masks the grievances of groups already disadvantaged by power inequity, further entrenching injustice.

Behavioral differences also play a role, in which women display lower risk taking including consume less tobacco, alcohol, and drugs, reducing their risk of mortality from associated diseases, including lung cancer, tuberculosis and cirrhosis. Other risk factors that are lower for women include motor vehicle accidents. Occupational differences have exposed women to less industrial injuries, although this is likely to change, as is risk of injury or death in war. Overall such injuries contributed to 3.5% of deaths in women compared to 6.2% in the United States in 2009. Suicide rates are also less in women.

The social view of health combined with the acknowledgement that gender is a social determinant of health inform women's health service delivery in countries around the world. Women's health services such as Leichhardt Women's Community Health Centre which was established in 1974 and was the first women's health centre established in Australia is an example of women's health approach to service delivery.

Women's health is an issue which has been taken up by many feminists, especially where reproductive health is concerned and the international women's movement was responsible for much of the adoption of agendas to improve women's health.

Biological factors
Factors that specifically affect the health of women compared to men are most evident in those related to reproduction, but sex differences have been identified from the molecular to the behavioral scale. Some of these differences are subtle and difficult to explain, partly due to the fact that it is difficult to separate the health effects of inherent biological factors from the effects of the surrounding environment they exist in. Women's XX sex chromosomes compliment, hormonal environment, as well as sex-specific lifestyles, metabolism, immune system function, and sensitivity to environmental factors are believed to contribute to sex differences in health at the levels of physiology, perception, and cognition. Women can have distinct responses to drugs and thresholds for diagnostic parameters. All of these necessitate caution in extrapolating information derived from biomarkers from one sex to the other. Young women and adolescents are at risk from STIs, pregnancy and unsafe abortion, while older women often have few resources and are disadvantaged with respect to men, and also are at risk of dementia and abuse, and generally poor health.

Reproductive and sexual health
Women experience many unique health issues related to reproduction and sexuality and these are responsible for a third of all health problems experienced by women during their reproductive years (aged 15–44), of which unsafe sex is a major risk factor, especially in developing countries. Reproductive health includes a wide range of issues including the health and function of structures and systems involved in reproduction, pregnancy, childbirth and child rearing, including antenatal and perinatal care. Global women's health has a much larger focus on reproductive health than that of developed countries alone, but also infectious diseases such as malaria in pregnancy and non-communicable diseases (NCD). Many of the issues that face women and girls in resource poor regions are relatively unknown in developed countries, such as female genital cutting, and further lack access to the appropriate diagnostic and clinical resources.

Maternal health
Pregnancy presents substantial health risks, even in developed countries, and despite advances in obstetrical science and practice. Maternal mortality remains a major problem in global health and is considered a sentinel event in judging the quality of health care systems. Adolescent pregnancy represents a particular problem, whether intended or unintended, and whether within marriage or a union or not. Pregnancy results in major changes in a girl's life, physically, emotionally, socially and economically and jeopardises her transition into adulthood. Adolescent pregnancy, more often than not, stems from a girl's lack of choices. or abuse. Child marriage (see below) is a major contributor worldwide, since 90% of births to girls aged 15–19 occur within marriage.

Maternal death
In 2013 about 289,000 women (800 per day) in the world died due to pregnancy-related causes, with large differences between developed and developing countries. In developed nations maternal mortality had been steadily falling and on average means 16 deaths per 100,000 live births, as measured by the maternal mortality ratio (MMR). By contrast rates as high as 1,000 deaths per 100,000 live births are reported in the rest of the world, with the highest rates in Sub-Saharan Africa and South Asia, which account for 86% of such deaths. These deaths are rarely investigated, yet the World Health Organization considers that 99% of these deaths, the majority of which occur within 24 hours of childbirth, are preventable if the appropriate infrastructure, training, and facilities were in place. In these resource-poor countries, maternal health is further eroded by poverty and adverse economic factors which impact the roads, health care facilities, equipment and supplies in addition to limited skilled personnel. Other problems include cultural attitudes towards sexuality, contraception, child marriage, home birth and the ability to recognise medical emergencies. The direct causes of these maternal deaths are hemorrhage, eclampsia, obstructed labor, sepsis and unskilled abortion. In addition malaria and AIDS can also endanger pregnancy. In the period 2003–2009 hemorrhage was the leading cause of death, accounting for 27% of deaths in developing countries and 16% in developed countries.

Non-reproductive health remains an important predictor of maternal health. In the United States, the leading causes of maternal death are cardiovascular disease (15% of deaths), endocrine, respiratory and gastrointestinal disorders, infection, hemorrhage and hypertensive disorders of pregnancy (Gronowski and Schindler, Table II).In 2000, the United Nations created Millennium Development Goal (MDG) 5 to improve maternal health. Target 5A sought to reduce maternal mortality by three quarters from 1990 to 2015, using two indicators, 5.1 the MMR and 5.2 the proportion of deliveries attended by skilled health personnel (physician, nurse or midwife). Early reports indicated MDG 5 had made the least progress of all MDGs. By the target date of 2015 the MMR had only declined by 45%, from 380 to 210, most of which occurred after 2000. However this improvement occurred across all regions, but the highest MMRs were still in Africa and Asia, although South Asia witnessed the largest fall, from 530 to 190 (64%). The smallest decline was seen in the developed countries, from 26 to 16 (37%). In terms of assisted births, this proportion had risen globally from 59 to 71%. Although the numbers were similar for both developed and developing regions, there were wide variations in the latter from 52% in South Asia to 100% in East Asia. The risks of dying in pregnancy in developing countries remains fourteen times higher than in developed countries, but in Sub-Saharan Africa, where the MMR is highest, the risk is 175 times higher. In setting the MDG targets, skilled assisted birth was considered a key strategy, but also an indicator of access to care and closely reflect mortality rates. There are also marked differences within regions with a 31% lower rate in rural areas of developing countries (56 vs. 87%), yet there is no difference in East Asia but a 52% difference in Central Africa (32 vs. 84%). With the completion of the MDG campaign in 2015, new targets are being set for 2030 under the Sustainable Development Goals campaign. Maternal health is placed under Goal 3, Health, with the target being to reduce the global maternal mortality ratio to less than 70. Amongst tools being developed to meet these targets is the WHO Safe Childbirth Checklist.

Improvements in maternal health, in addition to professional assistance at delivery, will require routine antenatal care, basic emergency obstetric care, including the availability of antibiotics, oxytocics, anticonvulsants, the ability to manually remove a retained placenta, perform instrumented deliveries, and postpartum care that is financially accessible, such as through insurance. Research has shown the most effective programmes are those focussing on patient and community education, prenatal care, emergency obstetrics (including access to cesarean sections) and transportation. As with women's health in general, solutions to maternal health require a broad view encompassing many of the other MDG goals, such as poverty and status, and given that most deaths occur in the immediate intrapartum period, it has been recommended that intrapartum care (delivery) be a core strategy. New guidelines on antenatal care were issued by WHO in November 2016.

Complications of pregnancy
In addition to death occurring in pregnancy and childbirth, pregnancy can result in many non-fatal health problems including obstetrical fistulae, ectopic pregnancy, preterm labor, gestational diabetes, hyperemesis gravidarum, hypertensive states including preeclampsia, and anemia. Globally, complications of pregnancy vastly outway maternal deaths, with an estimated 9.5 million cases of pregnancy-related illness and 1.4 million near-misses (survival from severe life-threatening complications). Complications of pregnancy may be physical, mental, economic and social. It is estimated that 10–20 million women will develop physical or mental disability every year, resulting from complications of pregnancy or inadequate care. Consequently, international agencies have developed standards for obstetric care.

Obstetrical fistula
Of near miss events, obstetrical fistulae (OF), including vesicovaginal and rectovaginal fistulae, remain one of the most serious and tragic. Although corrective surgery is possible it is often not available and OF is considered completely preventable. If repaired, subsequent pregnancies will require cesarean section. While unusual in developed countries, it is estimated that up to 100,000 cases occur every year in the world, and that about 2 million women are currently living with this condition, with the highest incidence occurring in Africa and parts of Asia. OF results from prolonged obstructed labor without intervention, when continued pressure from the fetus in the birth canal restricts blood supply to the surrounding tissues, with eventual fetal death, necrosis and expulsion. The damaged pelvic organs then develop a connection (fistula) allowing urine or feces, or both, to be discharged through the vagina with associated urinary and fecal incontinence, vaginal stenosis, nerve damage and infertility. Severe social and mental consequences are also likely to follow, with shunning of the women. Apart from lack of access to care, causes include young age, and malnourishment. The UNFPA has made prevention of OF a priority and is the lead agency in the Campaign to End Fistula, which issues annual reports and the United Nations observes May 23 as the International Day to End Obstetric Fistula every year. Prevention includes discouraging teenage pregnancy and child marriage, adequate nutrition, and access to skilled care, including caesarean section.

Contraception
The ability to determine if and when to become pregnant, is vital to a woman's autonomy and well-being, and contraception can protect girls and young women from the risks of early pregnancy and older women from the increased risks of unintended pregnancy. Adequate access to contraception can limit multiple pregnancies, reduce the need for potentially unsafe abortion and reduce maternal and infant mortality and morbidity. Some barrier forms of contraception such as condoms, also reduce the risk of STIs and HIV infection. Access to contraception allows women to make informed choices about their reproductive and sexual health, increases empowerment, and enhances choices in education, careers and participation in public life. At the societal level, access to contraception is a key factor in controlling population growth, with resultant impact on the economy, the environment and regional development. Consequently, the United Nations considers access to contraception a human right that is central to gender equality and women's empowerment that saves lives and reduces poverty, and birth control has been considered amongst the 10 great public health achievements of the 20th century.

To optimise women's control over pregnancy, it is essential that culturally appropriate contraceptive advice and means are widely, easily, and affordably available to anyone that is sexually active, including adolescents. In many parts of the world access to contraception and family planning services is very difficult or non existent and even in developed counties cultural and religious traditions can create barriers to access. Reported usage of adequate contraception by women has risen only slightly between 1990 and 2014, with considerable regional variability. Although global usage is around 55%, it may be as low as 25% in Africa. Research shows that women in the Middle East and North Africa use contraception at low rates. Only 14% of women who completed a survey in Jordan said they used condoms with their spouses. Worldwide 222 million women have no or limited access to contraception. Some caution is needed in interpreting available data, since contraceptive prevalence is often defined as "the percentage of women currently using any method of contraception among all women of reproductive age (i.e., those aged 15 to 49 years, unless otherwise stated) who are married or in a union. The "in-union" group includes women living with their partner in the same household and who are not married according to the marriage laws or customs of a country." This definition is more suited to the more restrictive concept of family planning, but omits the contraceptive needs of all other women and girls who are or are likely to be sexually active, are at risk of pregnancy and are not married or "in-union".

Three related targets of MDG5 were adolescent birth rate, contraceptive prevalence and unmet need for family planning (where prevalence+unmet need = total need), which were monitored by the Population Division of the UN Department of Economic and Social Affairs. Contraceptive use was part of Goal 5B (universal access to reproductive health), as Indicator 5.3. The evaluation of MDG5 in 2015 showed that amongst couples usage had increased worldwide from 55% to 64%. with one of the largest increases in Subsaharan Africa (13 to 28%). The corollary, unmet need, declined slightly worldwide (15 to 12%). In 2015 these targets became part of SDG5 (gender equality and empowerment) under Target 5.6: Ensure universal access to sexual and reproductive health and reproductive rights, where Indicator 5.6.1 is the proportion of women aged 15–49 years who make their own informed decisions regarding sexual relations, contraceptive use and reproductive health care (p. 31).

There remain significant barriers to accessing contraception for many women in both developing and developed regions. These include legislative, administrative, cultural, religious and economic barriers in addition to those dealing with access to and quality of health services. Much of the attention has been focused on preventing adolescent pregnancy. The Overseas Development Institute (ODI) has identified a number of key barriers, on both the supply and demand side, including internalising socio-cultural values, pressure from family members, and cognitive barriers (lack of knowledge), which need addressing. Even in developed regions many women, particularly those who are disadvantaged, may face substantial difficulties in access that may be financial and geographic but may also face religious and political discrimination. Women have also mounted campaigns against potentially dangerous forms of contraception such as defective intrauterine devices (IUD)s, particularly the Dalkon Shield.

Abortion
Abortion is the intentional termination of pregnancy, as compared to spontaneous termination (miscarriage). Abortion is closely allied to contraception in terms of women's control and regulation of their reproduction, and is often subject to similar cultural, religious, legislative and economic constraints. Where access to contraception is limited, women turn to abortion. Consequently, abortion rates may be used to estimate unmet needs for contraception. However the available procedures have carried great risk for women throughout most of history, and still do in the developing world, or where legal restrictions force women to seek clandestine facilities. Access to safe legal abortion places undue burdens on lower socioeconomic groups and in jurisdictions that create significant barriers. These issues have frequently been the subject of political and feminist campaigns where differing viewpoints pit health against moral values.

Globally, there were 87 million unwanted pregnancies in 2005, of those 46 million resorted to abortion, of which 18 million were considered unsafe, resulting in 68,000 deaths. The majority of these deaths occurred in the developing world. The United Nations considers these avoidable with access to safe abortion and post-abortion care. While abortion rates have fallen in developed countries, but not in developing countries. Between 2010 and 2014 there were 35 abortions per 1000 women aged 15–44, a total of 56 million abortions per year. The United nations has prepared recommendations for health care workers to provide more accessible and safe abortion and post-abortion care. An inherent part of post-abortion care involves provision of adequate contraception.

Sexually transmitted infections
Important sexual health issues for women include Sexually transmitted infections (STIs) and female genital cutting (FGC). STIs are a global health priority because they have serious consequences for women and infants. Mother-to-child transmission of STIs can lead to stillbirths, neonatal death, low-birth-weight and prematurity, sepsis, pneumonia, neonatal conjunctivitis, and congenital deformities. Syphilis in pregnancy results in over 300,000 fetal and neonatal deaths per year, and 215,000 infants with an increased risk of death from prematurity, low-birth-weight or congenital disease.

Diseases such as chlamydia and gonorrhoea are also important causes of pelvic inflammatory disease (PID) and subsequent infertility in women. Another important consequence of some STIs such as genital herpes and syphilis increase the risk of acquiring HIV by three-fold, and can also influence its transmission progression. Worldwide, women and girls are at greater risk of HIV/AIDS. STIs are in turn associated with unsafe sexual activity that is often unconsensual. In the Middle East and North Africa (MENA), a large number of HIV-positive women contracted the virus from their spouses or partners. In comparison to men, taboos, and discrimination against women living with HIV are more pervasive throughout the MENA region. Women in the MENA region are more vulnerable to HIV because of gender inequity, gender-based violence, and restricted access to comprehensive healthcare systems.

Female genital mutilation
Female genital mutilation (also referred to as female genital cutting) is defined by the World Health Organization (WHO) as "all procedures that involve partial or total removal of the external female genitalia, or other injury to the female genital organs for non-medical reasons". It has sometimes been referred to as female circumcision, although this term is misleading because it implies it is analogous to the circumcision of the foreskin from the male penis. Consequently, the term mutilation was adopted to emphasise the gravity of the act and its place as a violation of human rights. Subsequently, the term cutting was advanced to avoid offending cultural sensibility that would interfere with dialogue for change. To recognise these points of view some agencies use the composite female genital mutilation/cutting (FMG/C). It has affected more than 200 million women and girls who are alive today. The practice is concentrated in some 30 countries in Africa, the Middle East and Asia. Female genital mutilation is still common, impacting around 50 million women and girls in the five countries of Yemen, Egypt, Sudan, Djibouti, and Iraq in the Middle East and North Africa (MENA) region, as adolescent women frequently experience a lack of bodily autonomy in the Arab world. According to data, the frequency of FGM among women between the ages of 15 and 49 is high: 94% in Djibouti, 87% in Egypt and Sudan, 19% in Yemen, and 7% in Iraq. FGC affects many religious faiths, nationalities, and socioeconomic classes and is highly controversial. The main arguments advanced to justify FGC are hygiene, fertility, the preservation of chastity, an important rite of passage, marriageability and enhanced sexual pleasure of male partners. The amount of tissue removed varies considerably, leading the WHO and other bodies to classify FGC into four types. These range from the partial or total removal of the clitoris with or without the prepuce (clitoridectomy) in Type I, to the additional removal of the labia minora, with or without excision of the labia majora (Type II) to narrowing of the vaginal orifice (introitus) with the creation of a covering seal by suturing the remaining labial tissue over the urethra and introitus, with or without excision of the clitoris (infibulation). In this type a small opening is created to allow urine and menstrual blood to be discharged. Type 4 involves all other procedures, usually relatively minor alterations such as piercing.

While defended by those cultures in which it constitutes a tradition, FGC is opposed by many medical and cultural organizations on the grounds that it is unnecessary and harmful. Short-term health effects may include hemorrhage, infection, sepsis, and even result in death, while long term effects include dyspareunia, dysmenorrhea, vaginitis and cystitis. In addition FGC leads to complications with pregnancy, labor and delivery. Reversal (defibulation) by skilled personnel may be required to open the scarred tissue. Amongst those opposing the practice are local grassroots groups, and national and international organisations including WHO, UNICEF, UNFPA and Amnesty International. Legislative efforts to ban FGC have rarely been successful and the preferred approach is education and empowerment and the provision of information about the adverse health effects as well the human rights aspects.

Progress has been made but girls 14 and younger represent 44 million of those who have been cut, and in some regions 50% of all girls aged 11 and younger have been cut. Ending FGC has been considered one of the necessary goals in achieving the targets of the Millennium Development Goals, while the United Nations has declared ending FGC a target of the Sustainable Development Goals, and for February 6 to known as the International Day of Zero Tolerance for Female Genital Mutilation, concentrating on 17 African countries and the 5 million girls between the ages of 15 and 19 that would otherwise be cut by 2030.

Infertility
In the United States, infertility affects 1.5 million couples. The rates of infertility in the Middle East and North Africa (MENA) are difficult to measure due to varying definitions of the condition. When infertility is defined as failure to have a successful birth, the MENA region has a very high rate at 33%. Morocco has the highest percentage of infertility among the MENA countries with an infertility rate of 56.8%. Rates of infertility, defined as failure to conceive (clinical infertility), are probably lower in the region but there is a lack of data on the exact numbers. There is a dearth of research on clinical infertility in the MENA region, with the exception of Iran, which is attributed to a societal reluctance to discuss infertility openly.

Many couples seek assisted reproductive technology (ART) for infertility. In the United States in 2010, 147,260 in vitro fertilization (IVF) procedures were carried out, with 47,090 live births resulting. In 2013 these numbers had increased to 160,521 and 53,252. However, about a half of IVF pregnancies result in multiple-birth deliveries, which in turn are associated with an increase in both morbidity and mortality of the mother and the infant. Causes for this include increased maternal blood pressure, premature birth and low birth weight. In addition, more women are waiting longer to conceive and seeking ART.

Child marriage
Child marriage (including union or cohabitation) is defined as marriage under the age of eighteen and is an ancient custom. In 2010 it was estimated that 67 million women, then, in their twenties had been married before they turned eighteen, and that 150 million would be in the next decade, equivalent to 15 million per year. This number had increased to 70 million by 2012. In developing countries one third of girls are married under age, and 1:9 before 15. The practice is commonest in South Asia (48% of women), Africa (42%) and Latin America and the Caribbean (29%). The highest prevalence is in Western and Sub-Saharan Africa. The percentage of girls married before the age of eighteen is as high as 75% in countries such as Niger. Approximately one in five young women in the Middle East and North Africa were married before becoming eighteen, and one in twenty-five married before turning fifteen. In Egypt, 17% of women in the 20–24 age group, 13% in Morocco, 28% in Iraq, 8% in Jordan, 6% in Lebanon, and 3% in Algeria were married or engaged before turning 18. Most child marriage involves girls. For instance in Mali the ratio of girls to boys is 72:1, while in countries such as the United States the ratio is 8:1. Marriage may occur as early as birth, with the girl being sent to her husbands home as early as age seven.

There are a number of cultural factors that reinforce this practice. These include the child's financial future, her dowry, social ties and social status, prevention of premarital sex, extramarital pregnancy and STIs. The arguments against it include interruption of education and loss of employment prospects, and hence economic status, as well as loss of normal childhood and its emotional maturation and social isolation. Child marriage places the girl in a relationship where she is in a major imbalance of power and perpetuates the gender inequality that contributed to the practice in the first place. Also in the case of minors, there are the issues of human rights, non-consensual sexual activity and forced marriage and a 2016 joint report of the WHO and Inter-Parliamentary Union places the two concepts together as Child, Early and Forced Marriage (CEFM), as did the 2014 Girl Summit (see below). In addition the likely pregnancies at a young age are associated with higher medical risks for both mother and child, multiple pregnancies and less access to care with pregnancy being amongst the leading causes of death amongst girls aged 15–19. Girls married under age are also more likely to be the victims of domestic violence.

There has been an international effort to reduce this practice, and in many countries eighteen is the legal age of marriage. Organizations with campaigns to end child marriage include the United Nations and its agencies, such as the Office of the High Commissioner for Human Rights, UNFPA, UNICEF and WHO. Like many global issues affecting women's health, poverty and gender inequality are root causes, and any campaign to change cultural attitudes has to address these. Child marriage is the subject of international conventions and agreements such as The Convention on the Elimination of All Forms of Discrimination against Women (CEDAW, 1979) (article 16) and the Universal Declaration of Human Rights and in 2014 a summit conference (Girl Summit) co-hosted by UNICEF and the UK was held in London (see illustration) to address this issue together with FGM/C. Later that same year the General Assembly of the United Nations passed a resolution, which inter alia

"Urges all States to enact, enforce and uphold laws and policies aimed at preventing and ending child, early and forced marriage and protecting those at risk, and ensure that marriage is entered into only with the informed, free and full consent of the intending spouses (5 September 2014)"

Amongst non-governmental organizations (NGOs) working to end child marriage are Girls not Brides, Young Women's Christian Association (YWCA), the International Center for Research on Women (ICRW) and Human Rights Watch (HRW). Although not explicitly included in the original Millennium Development Goals, considerable pressure was applied to include ending child marriage in the successor Sustainable Development Goals adopted in September 2015, where ending this practice by 2030 is a target of SDG 5 Gender Equality (see above). While some progress is being made in reducing child marriage, particularly for girls under fifteen, the prospects are daunting. The indicator for this will be the percentage of women aged 20–24 who were married or in a union before the age of eighteen. Efforts to end child marriage include legislation and ensuring enforcement together with empowering women and girls. To raise awareness, the inaugural UN International Day of the Girl Child in 2012 was dedicated to ending child marriage.

Menstrual cycle
Women's menstrual cycles, the approximately monthly cycle of changes in the reproductive system, can pose significant challenges for women in their reproductive years (the early teens to about 50 years of age). These include the physiological changes that can effect physical and mental health, symptoms of ovulation and the regular shedding of the inner lining of the uterus (endometrium) accompanied by vaginal bleeding (menses or menstruation). The onset of menstruation (menarche) may be alarming to unprepared girls and mistaken for illness. Menstruation can place undue burdens on women in terms of their ability to participate in activities, and access to menstrual aids such as tampons and sanitary pads. This is particularly acute amongst poorer socioeconomic groups where they may represent a financial burden and in developing countries where menstruation can be an impediment to a girl's education. In the Middle East and North Africa, period poverty and stigma have an influence on girls' education and general well-being. Misinformation and a lack of fundamental knowledge cause girls to miss school during their menstrual cycle and contribute to the prevailing stigma around getting your period.

Equally challenging for women are the physiological and emotional changes associated with the cessation of menses (menopause or climacteric). While typically occurring gradually towards the end of the fifth decade in life marked by irregular bleeding the cessation of ovulation and menstruation is accompanied by marked changes in hormonal activity, both by the ovary itself (oestrogen and progesterone) and the pituitary gland (follicle stimulating hormone or FSH and luteinizing hormone or LH). These hormonal changes may be associated with both systemic sensations such as hot flashes and local changes to the reproductive tract such as reduced vaginal secretions and lubrication. While menopause may bring relief from symptoms of menstruation and fear of pregnancy it may also be accompanied by emotional and psychological changes associated with the symbolism of the loss of fertility and a reminder of aging and possible loss of desirability. While menopause generally occurs naturally as a physiological process it may occur earlier (premature menopause) as a result of disease or from medical or surgical intervention. When menopause occurs prematurely the adverse consequences may be more severe.

Other issues
Other reproductive and sexual health issues include sex education, puberty, sexuality and sexual function. Women also experience a number of issues related to the health of their breasts and genital tract, which fall into the scope of gynaecology.

Non-reproductive health
Women and men have different experiences of the same illnesses, especially cardiovascular disease, cancer, depression and dementia. Women are also more prone to urinary tract infections than men.

Cardiovascular disease
Cardiovascular disease is the leading cause of death (35%) amongst women globally. The onset occurs at a later age in women than in men. For instance the incidence of stroke in women under the age of 80 is less than that in men, but higher in those aged over 80. Overall the lifetime risk of stroke in women exceeds that in men. The risk of cardiovascular disease amongst those with diabetes and amongst smokers is also higher in women than in men. Many aspects of cardiovascular disease vary between women and men, including risk factors, prevalence, physiology, symptoms, response to intervention and outcome. Among women in the Middle East, cardiovascular disease-related morbidity and death are increasing. At the same time, awareness and education on the disease, as well as research, are lacking in the region.

Cancer
Women and men have approximately equal risk of dying from cancer, which accounts for about a quarter of all deaths, and is the second leading cause of death. However the relative incidence of different cancers varies between women and men. Globally the three most common types of cancer of women in 2020 were breast, lung and colorectal cancers. These three account for 44.5% of all cancer cases in women. Other types of cancers specifically affecting women include ovarian, uterine (endometrial and cervical) cancers.

While cancer death rates rose rapidly during the twentieth century, the increase was less and happened later in women due to differences in smoking rates. More recently cancer death rates have started to decline as the use of tobacco becomes less common. Between 1991 and 2012, the death rate in women declined by 19% (less than in men). In the early twentieth century death from uterine (uterine body and cervix) cancers was the leading cause of cancer death in women, who had a higher cancer mortality than men. From the 1930s onwards, uterine cancer deaths declined, primarily due to lower death rates from cervical cancer following the availability of the Papanicolaou (Pap) screening test. This resulted in an overall reduction of cancer deaths in women between the 1940s and 1970s, when rising rates of lung cancer led to an overall increase. By the 1950s the decline in uterine cancer left breast cancer as the leading cause of cancer death until it was overtaken by lung cancer in the 1980s. All three cancers (lung, breast, uterus) are now declining in cancer death rates, but more women die from lung cancer every year than from breast, ovarian, and uterine cancers combined. Overall about 20% of people found to have lung cancer are never smokers, yet amongst nonsmoking women the risk of developing lung cancer is three times greater than amongst men who never smoked.

In addition to mortality, cancer is a cause of considerable morbidity in women. Women have a lower lifetime probability of being diagnosed with cancer (38% vs 45% for men), but are more likely to be diagnosed with cancer at an earlier age.

Breast cancer
Breast cancer is most common type of cancer among women. Globally, it accounts for 25% of all cancers. It is also among the ten most common chronic diseases of women, and a substantial contributor to loss of quality of life. In 2016, breast cancer was the most common cancer diagnosed among women in both developed and developing countries, accounting for nearly 30% of all cases, and worldwide accounts for one and a half million cases and over half a million deaths, being the fifth most common cause of cancer death overall and the second in developed regions. In the Middle East and North Africa, there were 95,000 cases of breast cancer in 2019. The countries with the highest age-standardized prevalence rates per 100,000 females in the region were Bahrain, Qatar, and Lebanon. Geographic variation in incidence is the opposite of that of cervical cancer, being highest in Northern America and lowest in Eastern and Middle Africa, but mortality rates are relatively constant, resulting in a wide variance in case mortality, ranging from 25% in developed regions to 37% in developing regions, and with 62% of deaths occurring in developing countries.

Cervical cancer
Globally, cervical cancer is the fourth most common cancer amongst women. It is particularly common in women with lower socioeconomic status, living in low-and middle-income countries who have reduced access to health care. Customs and cultural practices that involve child and forced marriage, higher rates of parity, polygamy and exposure to STIs from multiple sexual contacts of male partners further increase the chances of cervical cancer. In developing countries, cervical cancer accounts for 12% of cancer cases amongst women and is the second leading cause of death, where about 85% of the global burden of over 500,000 cases and 250,000 deaths from this disease occurred in 2012. The highest incidence occurs in Eastern Africa, where with Middle Africa, cervical cancer is the commonest cancer in women. The case fatality rate of 52% is also higher in developing countries than in developed countries (43%), and the mortality rate varies by 18-fold between regions of the world.

Cervical cancer is associated with human papillomavirus (HPV), which has also been implicated in cancers of the vulva, vagina, anus, and oropharynx. Almost 300 million women worldwide have been infected with HPV, one of the commoner sexually transmitted infections, and 5% of the 13 million new cases of cancer in the world have been attributed to HPV. In developed countries, screening for cervical cancer using the Pap test has identified pre-cancerous changes in the cervix, at least in those women with access to health care. Also an HPV vaccine programme is available in 45 countries. Screening and prevention programmes have limited availability in developing countries although inexpensive low technology programmes are being developed, but access to treatment is also limited. If applied globally, HPV vaccination at 70% coverage could save the lives of 4 million women from cervical cancer, since most cases occur in developing countries.

Ovarian cancer
Ovarian cancer is the eighth most common cancer globally. It is predominantly a disease of women in industrialized countries and death from ovarian cancer is more common in North America and Europe than in Africa and Asia. Because it is largely asymptomatic in its earliest stages and lacks an effective screening programme, more than 50% of women have stage III or higher cancer (spread beyond the ovaries) by the time they are diagnosed, with a consequent poor prognosis.

Mental health
Almost 25% of women will experience mental health issues over their lifetime. Women are at higher risk than men from anxiety, depression, and psychosomatic complaints. Globally, depression is the leading disease burden. In the United States, women have depression twice as often as men. The economic costs of depression in American women are estimated to be $20 billion every year. The risks of depression in women have been linked to changing hormonal environment that women experience, including puberty, menstruation, pregnancy, childbirth and the menopause. Women also metabolise drugs used to treat depression differently to men. Suicide rates are less in women than men (<1% vs. 2.4%), but are a leading cause of death for women under the age of 60. In the United Kingdom, the Women's Mental Health Taskforce was formed aiming to address differences in mental health experiences and needs between women and men.

Dementia
The prevalence of Alzheimer's disease in the United States is estimated at 5.1 million, and of these two thirds are women. Furthermore, women are far more likely to be the primary caregivers of adult family members with dementia, so that they bear both the risks and burdens of this disease. The lifetime risk for a woman of developing Alzheimer's disease is twice that of men. Part of this difference may be due to life expectancy, but changing hormonal status over their lifetime may also play a par as may differences in gene expression. Deaths due to dementia are higher in women than men (4.5% of deaths vs. 2.0%).

Bone health
Osteoporosis ranks sixth amongst chronic diseases of women in the United States, with an overall prevalence of 18%, and a much higher rate involving the femur, neck or lumbar spine amongst women (16%) than men (4%), over the age of 50. Osteoporosis is a risk factor for bone fracture and about 20% of senior citizens who sustain a hip fracture die within a year. The gender gap is largely the result of the reduction of estrogen levels in women following the menopause. Hormone Replacement Therapy (HRT) has been shown to reduce this risk by 25–30%, and was a common reason for prescribing it during the 1980s and 1990s. However the Women's Health Initiative (WHI) study that demonstrated that the risks of HRT outweighed the benefits has since led to a decline in HRT usage.

Anaemia
Anaemia is a major global health problem for women. Women are affected more than men, in which up to 30% of women being found to be anaemic and 42% of pregnant women. Anaemia is linked to a number of adverse health outcomes including a poor pregnancy outcome and impaired cognitive function (decreased concentration and attention). The main cause of anaemia is iron deficiency. In United States women iron deficiency anaemia (IDA) affects 37% of pregnant women, but globally the prevalence is as high as 80%. Anaemia affects over one-third of the population in the Middle East and North Africa, caused by iron deficiencies or a combination of other factors, with women making up the bulk of those affected. In Saudi Arabia, 40% of women in the 15–49 age range suffer from anaemia. IDA starts in adolescence, from excess menstrual blood loss, compounded by the increased demand for iron in growth and suboptimal dietary intake. In the adult woman, pregnancy leads to further iron depletion.

Violence
Women experience structural and personal violence differently than men. The United Nations has defined violence against women as; "' any act of gender-based violence that results in, or is likely to result in, physical, sexual or mental harm or suffering to women, including threats of such acts, coercion or arbitrary deprivation of liberty, whether occurring in public or in private life.' (United Nations, Declaration on the Elimination of Violence against Women, 1993)" Violence against women may take many forms, including physical, sexual, emotional and psychological and may occur throughout the life-course. Structural violence may be embedded in legislation or policy, or be systematic misogyny by organisations against groups of women. Perpetrators of personal violence include state actors, strangers, acquaintances, relatives and intimate partners and manifests itself across a spectrum from discrimination, through harassment, sexual assault and rape, and physical harm to murder (femicide). It may also include cultural practices such as female genital cutting.

Non-fatal violence against women has severe implications for women's physical, mental and reproductive health, and is seen as not simply isolated events but rather a systematic pattern of behaviour that both violates their rights but also limits their role in society and requires a systematic approach.

The World Health Organization (WHO) estimates that 35% of women in the world have experienced physical or sexual violence over their lifetime and that the commonest situation is intimate partner violence. 30% of women in relationships report such experience, and 38% of murders of women are due to intimate partners. These figures may be as high as 70% in some regions. Risk factors include low educational achievement, a parental experience of violence, childhood abuse, gender inequality and cultural attitudes that allow violence to be considered more acceptable.

The COVID-19 epidemic made gender-based violence more common in Arab countries and worsened already-existing health disparities between the sexes. Yet millions of women in the Middle East and North Africa did not receive enough attention when it came to the provision of enhanced protection from gender-based violence.

Violence was declared a global health priority by the WHO at its assembly in 1996, drawing on both the United Nations Declaration on the elimination of violence against women (1993) and the recommendations of both the International Conference on Population and Development (Cairo, 1994) and the Fourth World Conference on Women (Beijing, 1995) This was followed by its 2002 World Report on Violence and Health, which focusses on intimate partner and sexual violence. Meanwhile, the UN embedded these in an action plan when its General Assembly passed the Millennium Declaration in September 2000, which resolved inter alia "to combat all forms of violence against women and to implement the Convention on the Elimination of All Forms of Discrimination against Women". One of the Millennium Goals (MDG 3) was the promotion of gender equality and the empowerment of women, which sought to eliminate all forms of violence against women as well as implementing CEDAW. This recognised that eliminating violence, including discrimination was a prerequisite to achieving all other goals of improving women's health. However it was later criticised for not including violence as an explicit target, the "missing target". In the evaluation of MDG 3, violence remained a major barrier to achieving the goals. In the successor Sustainable Development Goals, which also explicitly list the related issues of discrimination, child marriage and genital cutting, one target is listed as "Eliminate all forms of violence against all women and girls in the public and private spheres" by 2030.

UN Women believe that violence against women "is rooted in gender-based discrimination and social norms and gender stereotypes that perpetuate such violence", and advocate moving from supporting victims to prevention, through addressing root and structural causes. They recommend programmes that start early in life and are directed towards both genders to promote respect and equality, an area often overlooked in public policy. This strategy, which involves broad educational and cultural change, also involves implementing the recommendations of the 57th session of the UN Commission on the Status of Women (2013). To that end the 2014 UN International Day of the Girl Child was dedicated to ending the cycle of violence. In 2016, the World Health Assembly also adopted a plan of action to combat violence against women, globally.

Women in health research
Changes in the way research ethics was visualised in the wake of the Nuremberg Trials (1946), led to an atmosphere of protectionism of groups deemed to be vulnerable that was often legislated or regulated. This resulted in the relative underrepresentation of women in clinical trials. The position of women in research was further compromised in 1977, when in response to the tragedies resulting from thalidomide and diethylstilbestrol (DES), the United States Food and Drug Administration (FDA) prohibited women of child-bearing years from participation in early stage clinical trials. In practice this ban was often applied very widely to exclude all women. Women, at least those in the child-bearing years, were also deemed unsuitable research subjects due to their fluctuating hormonal levels during the menstrual cycle. However, research has demonstrated significant biological differences between the sexes in rates of susceptibility, symptoms and response to treatment in many major areas of health, including heart disease and some cancers. These exclusions pose a threat to the application of evidence-based medicine to women, and compromise to care offered to both women and men.

The increasing focus on Women's Rights in the United States during the 1980s focused attention on the fact that many drugs being prescribed for women had never actually been tested in women of child-bearing potential, and that there was a relative paucity of basic research into women's health. In response to this the National Institutes of Health (NIH) created the Office of Research on Women's Health (ORWH) in 1990 to address these inequities. In 1993 the National Institutes of Health Revitalisation Act officially reversed US policy by requiring NIH funded phase III clinical trials to include women. This resulted in an increase in women recruited into research studies. The next phase was the specific funding of large scale epidemiology studies and clinical trials focussing on women's health such as the Women's Health Initiative (1991), the largest disease prevention study conducted in the US. Its role was to study the major causes of death, disability and frailty in older women. Despite this apparent progress, women remain underrepresented. In 2006 women accounted for less than 25% of clinical trials published in 2004, A follow-up study by the same authors five years later found little evidence of improvement. Another study found between 10 and 47% of women in heart disease clinical trials, despite the prevalence of heart disease in women. Lung cancer is the leading cause of cancer death amongst women, but while the number of women enrolled in lung cancer studies is increasing, they are still far less likely to be enrolled than men.

One of the challenges in assessing progress in this area is the number of clinical studies that either do not report the gender of the subjects or lack the statistical power to detect gender differences. These were still issues in 2014, and further compounded by the fact that the majority of animal studies also exclude females or fail to account for differences in sex and gender. for instance despite the higher incidence of depression amongst women, less than half of the animal studies use female animals. Consequently, a number of funding agencies and scientific journals are asking researchers to explicitly address issues of sex and gender in their research. Some countries address the underrepresentation of women in research studies by the establishment of centers of excellence focusing on women's health research and running large scale clinical trials such as the Women's Health Initiative.

A related issue is the inclusion of pregnant women in clinical studies. Since other illnesses can exist concurrently with pregnancy, information is needed on the response to and efficacy of interventions during pregnancy, but ethical issues relative to the fetus, make this more complex. This gender bias is partly offset by the initiation of large scale epidemiology studies of women, such as the Nurses' Health Study (1976), Women's Health Initiative and Black Women's Health Study.

Women have also been the subject of neglect in health care research, such as the situation revealed in the Cartwright Inquiry in New Zealand (1988), in which research by two feminist journalists revealed that women with cervical abnormalities were not receiving treatment, as part of an experiment. The women were not told of the abnormalities and several later died.

The Women's Health Care Market is today a major pharmaceutical industry, projected to double in size within the five years from 2019 to 2024 and reach USD 17.8 billion. The by far most valued company worldwide whose leading products are in Women's Health is Bayer (Germany) with the focus area of Contraception.

National and international initiatives
In addition to addressing gender inequity in research, a number of countries have made women's health the subject of national initiatives. For instance in 1991 in the United States, the Department of Health and Human Services established an Office on Women's Health (OWH) with the goal of improving the health of women in America, through coordinating the women's health agenda throughout the department, and other agencies. In the twenty first century the Office has focussed on underserviced women. Also, in 1994 the Centers for Disease Control and Prevention (CDC) established its own Office of Women's Health (OWH), which was formally authorised by the 2010 Affordable Health Care Act (ACA).

Internationally, many United Nations agencies such as the World Health Organization (WHO), United Nations Population Fund (UNFPA) and UNICEF maintain specific programs on women's health, or maternal, sexual and reproductive health. In addition the United Nations global goals address many issues related to women's health, both directly and indirectly. These include the 2000 Millennium Development Goals (MDG) and their successor, the Sustainable Development Goals adopted in September 2015, following the report on progress towards the MDGs (The Millennium Development Goals Report 2015). For instance the eight MDG goals, eradicating extreme poverty and hunger, achieving universal primary education, promoting gender equality and empowering women, reducing child mortality rates, improving maternal health, combating HIV/AIDS malaria and other diseases, ensuring environmental sustainability, and developing a global partnership for development, all impact on women's health, as do all seventeen SDG goals, in addition to the specific SDG5: Achieve gender equality and empower all women and girls.

Goals and challenges
Research is a priority in terms of improving women's health. Research needs include diseases unique to women, more serious in women and those that differ in risk factors between women and men. The balance of gender in research studies needs to be balanced appropriately to allow analysis that will detect interactions between gender and other factors. Gronowski and Schindler suggest that scientific journals make documentation of gender a requirement when reporting the results of animal studies, and that funding agencies require justification from investigators for any gender inequity in their grant proposals, giving preference to those that are inclusive. They also suggest it is the role of health organisations to encourage women to enroll in clinical research. However, there has been progress in terms of large scale studies such as the WHI, and in 2006 the Society for Women's Health Research founded the Organization for the Study of Sex Differences and the journal Biology of Sex Differences to further the study of sex differences.

Research findings can take some time before becoming routinely implemented into clinical practice. Clinical medicine needs to incorporate the information already available from research studies as to the different ways in which diseases affect women and men. Many "normal" laboratory values have not been properly established for the female population separately, and similarly the "normal" criteria for growth and development. Drug dosing needs to take gender differences in drug metabolism into account.

Globally, women's access to health care remains a challenge, both in developing and developed countries. In the United States, before the Affordable Health Care Act came into effect, 25% of women of child-bearing age lacked health insurance. In the absence of adequate insurance, women are likely to avoid important steps to self care such as routine physical examination, screening and prevention testing, and prenatal care. The situation is aggravated by the fact that women living below the poverty line are at greater risk of unplanned pregnancy, unplanned delivery and elective abortion. Added to the financial burden in this group are poor educational achievement, lack of transportation, inflexible work schedules and difficulty obtaining child care, all of which function to create barriers to accessing health care. These problems are much worse in developing countries. Under 50% of childbirths in these countries are assisted by healthcare providers (e.g. midwives, nurses, doctors) which accounts for higher rates of maternal death, up to 1:1,000 live births. This is despite the WHO setting standards, such as a minimum of four antenatal visits. A lack of healthcare providers, facilities, and resources such as formularies all contribute to high levels of morbidity amongst women from avoidable conditions such as obstetrical fistulae, sexually transmitted infections and cervical cancer.

These challenges are included in the goals of the Office of Research on Women's Health, in the United States, as is the goal of facilitating women's access to careers in biomedicine. The ORWH believes that one of the best ways to advance research in women's health is to increase the proportion of women involved in healthcare and health research, as well as assuming leadership in government, centres of higher learning, and in the private sector. This goal acknowledges the glass ceiling that women face in careers in science and in obtaining resources from grant funding to salaries and laboratory space. The National Science Foundation in the United States states that women only gain half of the doctorates awarded in science and engineering, fill only 21% of full-time professor positions in science and 5% of those in engineering, while earning only 82% of the remuneration their male colleagues make. These figures are even lower in Europe.

Women's health by country

 * Women's health in China
 * Women's health in Ethiopia
 * Women's health in India

Publications

 * Global Library of Women's Medicine
 * Health Care for Women International
 * Journal of Women's Health
 * Our Bodies, Ourselves
 * Women & Health
 * Women's Health Issues

Articles

 * , in
 * , in
 * , in
 * , in
 * , in
 * , in
 * }
 * , in
 * , in
 * , in
 * , in
 * , in
 * , in
 * , in
 * }
 * , in
 * , in
 * , in
 * , in
 * , in
 * , in
 * }
 * , in
 * , in
 * , in
 * , in
 * , in
 * }
 * , in
 * , in
 * }
 * , in
 * }
 * , in
 * }
 * , in
 * }
 * , in
 * , in
 * , in
 * , in
 * , in

Reproductive and sexual health

 * , in

Chapters

 * , in
 * , in
 * , in
 * , in

Organizations

 * see American Congress of Obstetricians and Gynecologists
 * see Human Rights Watch
 * see Overseas Development Institute
 * see Save the Children
 * see Human Rights Watch
 * see Overseas Development Institute
 * see Save the Children
 * see Human Rights Watch
 * see Overseas Development Institute
 * see Save the Children
 * see Overseas Development Institute
 * see Save the Children

WHO

 * , in
 * , in

CDC

 * , in
 * , in
 * , in

license: Creative Commons - Attribution Share-Alike - https://creativecommons.org/licenses/by-sa/4.0/

title: Women's health


text:
Magny

Magny (pro. mah-NJEE) is the name or part of the name of the following communes in France:

 * Magny, Eure-et-Loir, in the Eure-et-Loir department
 * Magny, Haut-Rhin, in the Haut-Rhin department
 * Magny, Yonne, in the Yonne department
 * Magny-Châtelard, in the Doubs department
 * Magny-Cours, in the Nièvre department
 * Magny-Danigon, in the Haute-Saône department
 * Magny-en-Bessin, in the Calvados department
 * Magny-en-Vexin, in the Val-d'Oise department
 * Magny-Fouchard, in the Aube department
 * Magny-Jobert, in the Haute-Saône department
 * Magny-la-Campagne, in the Calvados department
 * Magny-la-Fosse, in the Aisne department
 * Magny-Lambert, in the Côte-d'Or department
 * Magny-la-Ville, in the Côte-d'Or department
 * Magny-le-Désert, in the Orne department
 * Magny-le-Freule, in the Calvados department
 * Magny-le-Hongre, in the Seine-et-Marne department
 * Magny-lès-Aubigny, in the Côte-d'Or department
 * Magny-les-Hameaux, in the Yvelines department
 * Magny-lès-Jussey, in the Haute-Saône department
 * Magny-lès-Villers, in the Côte-d'Or department
 * Magny-Lormes, in the Nièvre department
 * Magny-Montarlot, in the Côte-d'Or department
 * Magny-Saint-Médard, in the Côte-d'Or department
 * Magny-sur-Tille, in the Côte-d'Or department
 * Magny-Vernois, in the Haute-Saône department
 * Hyèvre-Magny, in the Doubs department
 * Robert-Magny-Laneuville-à-Rémy, in the Haute-Marne department
 * Vincy-Reuil-et-Magny, in the Aisne department

title: Magny